- Home
- AES vs QGEN Comparison
AES vs QGEN Comparison
Compare AES & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AES | QGEN |
|---|---|---|
| Founded | 1981 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 10.2B |
| IPO Year | 1996 | 1998 |
Fundamental Metrics
Financial Performance| Metric | AES | QGEN |
|---|---|---|
| Price | $14.65 | $39.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 8 |
| Target Price | $15.29 | ★ $45.76 |
| AVG Volume (30 Days) | ★ 7.4M | 2.2M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | 4.87% | ★ 7.17% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $12,233,000,000.00 | N/A |
| Revenue This Year | $5.22 | $8.18 |
| Revenue Next Year | $4.81 | $5.71 |
| P/E Ratio | ★ $21.54 | $24.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.02 | $32.53 |
| 52 Week High | $17.65 | $57.82 |
Technical Indicators
Market Signals| Indicator | AES | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 63.87 |
| Support Level | $14.59 | $38.80 |
| Resistance Level | $15.02 | $49.27 |
| Average True Range (ATR) | 0.06 | 0.80 |
| MACD | -0.01 | 0.26 |
| Stochastic Oscillator | 60.00 | 90.18 |
Price Performance
Historical ComparisonAbout AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).